Dr. Suresh Kumar

Assistant Professor
Pharmaceutical Chemistry


Professional Biography

Suresh Kumar is an expert in the area of pharmaceutical and medicinal chemistry. He has taught these subjects at universities and colleges which includes, DIPSAR (Delhi University) & SD college of Pharmacy & Vocational Studies (Muzaffarnagar, UP) and Amity University, Noida. He has more than 10 years of experience which spreads across academic, research and industry.

Before taking up the current role in 2019, Suresh had served in the pharmaceutical industry as an Intellectual Property Right (IPR) professionalat at different levels such as Research Manager, Assistant Manager in Stride Pharma Ltd., Chennai and as a Research Scientist in Jubilant Life Science Ltd. Noida, India.

Suresh holds a PhD and Master degree in Pharmaceutical Chemistry from Jamia Hamdard University, New Delhi; and Bachelor of Pharmacy from DIPSAR, University of Delhi.

Publications (from 2015)

Scholarly Journals
‘Development of thiazole-5-carboxylate derivatives as selective inhibition of monoacylglycerol lipase as a target in Cancer’, Mini-Reviews in Medicinal Chemistry, 19(5), pp. 410-423. (Ali. M.R., Kumar, S. Bawa, S., 2019).

‘Development of 2‐(substituted benzylamino)‐4‐methyl‐1, 3‐thiazole‐5‐carboxylic acid derivatives as xanthine oxidase inhibitors and free radical scavengers’, Chemical Biology & Drug Design, 87(4), pp. 508-516. (Ali. M.R., Kumar, S. et al., 2016).

‘2‐Benzamido‐4‐methylthiazole‐5‐carboxylic acid derivatives as potential xanthine oxidase inhibitors and free radical scavengers’, Archiv der Pharmazie- Chemistry in Life sciences, 350(02), pp. 1600313. (Ali. M.R., Kumar, S. et al., 2017).

‘Discovery of novel beta-lactam amalgamated 4-methylthiazole-5-carboxylic acid derivatives as potential antimicrobial agents’, Acta Poloniae pharmaceutica- drug research, 74, pp. 1699-1709. (Arshad, M.F., Al-Otaibi, F., Kumar, S. et al., 2017).

‘Synthesis of 3-chloro-4-fluorophenyl-3, 4-dichlorophenyl substituted thiocarbamide derivatives as potential anti-tubercular agents’, Medicinal Chemistry Research, 24, pp.334–343. (Arshad, M.F., Kumar, S. et al, 2015).

‘Comparative atom based 3D QSAR study of 3-nitro-1H-1,2,4-triazole-based aliphatic and aromatic amines analogs for its anti-trypanosomal activities’, Medicinal Chemistry Research, 24, pp. 22-31. (Kumar, S. Agarwal, R., Bawa, S. 2015).

‘In-vitro antibacterial / antifungal screening of 2-chloroquinoline scaffold derivatives’, Journal of Antibiotics Research, 01, pp. 1-11. (Kumar, S., Goel, N. et al, 2017).

‘NaBH4/I2 mediated one-pot synthesis of 4-(substituted-anilinomethyl-3-(6-methoxy-2-naphthyl)-1-phenyl-1H-pyrazoles and their antimicrobial screening’, Bulgarian Chemical Communications, 47, pp. 502–508. (Kumar, S., Goel, N. et al, 2015).

Contribution to the Profession and Awards

Technical Editor, Journal of Pharmacy and Bio Allied Sciences (Publisher, Medknow Publications).

Reviewer, European Journal of Medicinal Chemistry (Elsevier Publications)

Post-Doctoral Fellowship, CSIR-RA

UGC-JRF in Engineering & Technology for Ph.D.

UGC-GATE Fellowship for M. Pharm

Current Research

Suresh Kumar’s core areas of research include design, synthesis, and spectral characterization of novel anti-microbial agents including anti-tubercular agents, anticancer agents, anticonvulsant agents, xanthine oxidase inhibitors etc.